Document Detail

Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells.
MedLine Citation:
PMID:  16076371     Owner:  NLM     Status:  MEDLINE    
Involvement of the activation of neutrophils and vascular endothelial cells in the pathology of sepsis has recently been reported. We therefore investigated whether direct hemoperfusion (DHP) with a polymyxin B immobilized fiber column (PMX) could reduce the level of plasminogen activator inhibitor-1 (PAI-1), an index of vascular endothelial cell activation. Twelve sepsis patients satisfying the following criteria were enrolled in the study: (i) stable global oxygen metabolism (oxygen delivery index>500 mL/min/m2 and oxygen consumption index>120 mL/min/m2); (ii) abnormal tissue oxygen metabolism (PCO2 gap: gastric mucosal PCO2 minus arterial PCO2 difference>8 mm Hg); and (iii) mean blood pressure>or=60 mm Hg. Direct hemoperfusion with PMX was performed twice (for 3 h each time) within 24 h. Plasminogen activator inhibitor-1 was measured a total of 5 times: before PMX-DHP, immediately after the first DHP with PMX session (3 h after the start), and 24, 48, and 72 h afterward. The PAI-1 value was 150+/-30.0 ng/mL before DHP with PMX, 178+/-60.0 ng/mL immediately after DHP with PMX, 90+/-22.1 ng/mL at 24 h after, 65+/-21.0 ng/mL at 48 h after, and 64+/-18.3 ng/mL 72 h after. The values were significantly lower from 48 h onward compared with baseline. These data suggest that DHP with PMX inhibits vascular endothelial cell activation.
Hidehiko Kushi; Jun Nakahara; Takahiro Miki; Kazuhiko Okamoto; Takeshi Saito; Kastuhisa Tanjo
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy     Volume:  9     ISSN:  1744-9979     ISO Abbreviation:  Ther Apher Dial     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-03     Completed Date:  2005-12-13     Revised Date:  2006-11-07    
Medline Journal Info:
Nlm Unique ID:  101181252     Medline TA:  Ther Apher Dial     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  303-7     Citation Subset:  IM    
Department of Emergency and Critical Care Medicine, Nihon University School of Medicine, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Anti-Bacterial Agents / administration & dosage,  therapeutic use*
Endothelial Cells / drug effects*
Hemoperfusion / methods*
Middle Aged
Patient Selection
Plasminogen Activator Inhibitor 1 / blood
Polymyxin B / administration & dosage,  therapeutic use*
Sepsis / blood,  therapy*
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Plasminogen Activator Inhibitor 1; 1404-26-8/Polymyxin B

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment with cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and ...
Next Document:  Fibroblast growth factor 23 and its receptors.